Anvisa prioritizes registration of dengue devices
At the public meeting, Brazil’s National Health Surveillance Agency (Anvisa) announced an urgent decision: it will prioritize all applications for registration of dengue diagnostic devices. The aim is to guarantee effective means for early diagnosis and a faster response in controlling the epidemic.
If you need more information about regulatory issues in the pharmaceutical industry and healthcare, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
